Literature DB >> 4884297

Quinine, pyrimethamine, and sulphorthodimethoxine: clinical response, plasma levels, and urinary excretion during the initial attack of naturally acquired falciparum malaria.

M H Brooks, J P Malloy, P J Bartelloni, T W Sheehy, K G Barry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4884297     DOI： 10.1002/cpt196910185

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

1.  Evaluation of an in vitro test method for the assessment of sensitivity of Plasmodium falciparum to pyrimethamine and sulfadoxine.

Authors:  A Sabchareon; T Chongsuphajaisiddhi; P Attanath; B Meemanee; W Wernsdorfer
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

2.  Falciparum malaria cured by quinine followed by sulfadoxine-pyrimethamine.

Authors:  A P Hall; E B Doberstyn; V Mettaprakong; P Sonkom
Journal:  Br Med J       Date:  1975-04-05

3.  Falciparum malaria semi-resistant to clindamycin.

Authors:  A P Hall; E B Doberstyn; A Nanokorn; P Sonkom
Journal:  Br Med J       Date:  1975-04-05

4.  Disposition of oral quinine in acute falciparum malaria.

Authors:  W Supanaranond; T M Davis; S Pukrittayakamee; K Silamut; J Karbwang; P Molunto; L Chanond; N J White
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.

Authors:  A Sabchareon; T Chongsuphajaisiddhi; P Attanath; K Kanjanapipatkul; E B Doberstyn; L Suebsaeng
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 6.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 7.  Antimalarial drugs. An update.

Authors:  D C Warhurst
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

8.  Characterization of a common binding site for basic drugs on human alpha 1-acid glycoprotein (orosomucoid).

Authors:  W E Müller; A E Stillbauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000

9.  Potentiating effect of pyrimethamine and sulfadoxine against dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.

Authors:  W Sirawaraporn; Y Yuthavong
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.